It's all about earnings. I expect costs to be down and revenues up thanks to the established salesforce and new products like skin care. Medipets should be getting traction also. If Hagen can pull off half to one million in earnings then we are off to the races. The icing on the cake will be disgorgement of 300-500 million shares and their removal from the market, uplist, removal of CE. This is all the best scenario, do your DD, there is risk here and a lot of upside potential also.